Table 1.
Patients' characteristics at baseline (n = 12)
| Median age (range), years | 63.5 (33–72) |
| Gender, n (%) | |
| Male | 9 (75) |
| Female | 3 (25) |
| Primary tumor, n (%) | |
| Intrahepatic | 9 (75) |
| Hilar | 2 (17) |
| Gallbladder | 1 (8) |
| Nodal involvement, n (%) | |
| cN0 | 8 (67) |
| cN+ | 4 (33) |
| Grade, n (%) | |
| G1 | 0 (0) |
| G2 | 1 (8) |
| G3 | 5 (42) |
| Unknown | 6 (50) |
| ECOG, n (%) | |
| 0 | 3 (25) |
| 1 | 9 (75) |
| Previous chemotherapy, n (%) Liver function tests |
2 (17) |
| ALT abnormal, n (range in U/L) (%) | 7 (64–168) (58) |
| AST abnormal, n (range in U/L) (%) | 9 (71–174) (75) |
| Bilirubin abnormal, n (range in umol/L) (%) | 2 (3–41) (17) |